Author: Baldock, Claire

Source: Journal of Commercial Biotechnology, Volume 12, Number 2, 1 January 2006 , pp. 120-126(7)

Publisher: Palgrave Macmillan

Abstract:

The patenting of embryonic stem cell-related inventions appears to be as controversial as the technology itself. The author outlines the state of play in Europe and the USA as well as other selected territories. While Europe has the broadest statutory exclusions to patenting of inventions which might be regarded as unethical, it appears that a smooth ride for applicants and patent holders is not guaranteed elsewhere.Journal of Commercial Biotechnology (2006) 12, 120-126; doi:10.1057/palgrave.jcb.3040158

Document Type: Research article

DOI: http://dx.doi.org/10.1057/palgrave.jcb.3040158

Publication date: 2006-01-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Biotechnology
• By this author: Baldock, Claire

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers